Didem Şener Dede

1.1k total citations
50 papers, 768 citations indexed

About

Didem Şener Dede is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Didem Şener Dede has authored 50 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Didem Şener Dede's work include Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Didem Şener Dede is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Didem Şener Dede collaborates with scholars based in Türkiye, United States and United Kingdom. Didem Şener Dede's co-authors include Sercan Aksoy, Kadri Altundağ, Hakan Harputluoğlu, Saadettin Kılıçkap, Ömer Dızdar, İbrahim Barışta, Mehmet Alı Nahıt Şendur, Bülent Yalçın, Muhammed Bülent Akıncı and Burak Bi̇lgi̇n and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Geriatrics Society.

In The Last Decade

Didem Şener Dede

40 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didem Şener Dede Türkiye 13 286 160 116 94 80 50 768
Burhan Turgut Türkiye 19 217 0.8× 130 0.8× 129 1.1× 132 1.4× 87 1.1× 69 911
Beata Naumnik Poland 16 111 0.4× 135 0.8× 102 0.9× 153 1.6× 147 1.8× 78 885
Biruh Workeneh United States 15 225 0.8× 270 1.7× 70 0.6× 354 3.8× 148 1.9× 55 1.2k
Burak Uz Türkiye 13 168 0.6× 50 0.3× 87 0.8× 56 0.6× 113 1.4× 44 604
Miroslav Samaržija Croatia 18 277 1.0× 547 3.4× 184 1.6× 203 2.2× 96 1.2× 121 1.1k
Guangchang Pei China 18 261 0.9× 147 0.9× 83 0.7× 306 3.3× 232 2.9× 35 1.3k
Fatma Belgin Ataç Türkiye 17 74 0.3× 138 0.9× 135 1.2× 68 0.7× 124 1.6× 70 785
Sven H. Loosen Germany 14 151 0.5× 101 0.6× 186 1.6× 144 1.5× 164 2.0× 99 713
Murat Karaman Türkiye 20 246 0.9× 154 1.0× 182 1.6× 115 1.2× 312 3.9× 62 1.2k
Erol Arslan Türkiye 16 78 0.3× 92 0.6× 120 1.0× 194 2.1× 200 2.5× 52 826

Countries citing papers authored by Didem Şener Dede

Since Specialization
Citations

This map shows the geographic impact of Didem Şener Dede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didem Şener Dede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didem Şener Dede more than expected).

Fields of papers citing papers by Didem Şener Dede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didem Şener Dede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didem Şener Dede. The network helps show where Didem Şener Dede may publish in the future.

Co-authorship network of co-authors of Didem Şener Dede

This figure shows the co-authorship network connecting the top 25 collaborators of Didem Şener Dede. A scholar is included among the top collaborators of Didem Şener Dede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didem Şener Dede. Didem Şener Dede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi̇lgi̇n, Burak, Bülent Yalçın, Muhammed Bülent Akıncı, et al.. (2025). Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis. Cancers. 17(3). 424–424. 1 indexed citations
2.
3.
Dede, Didem Şener, et al.. (2025). Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer. Current Issues in Molecular Biology. 47(2). 121–121.
4.
Dede, Didem Şener, Burak Bi̇lgi̇n, Şebnem Çınar Yücel, et al.. (2024). Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 14(1). 173–173.
5.
Bi̇lgi̇n, Burak, Mehmet Alı Nahıt Şendur, Nalân Akyürek, et al.. (2021). The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement. Journal of Cancer Research and Clinical Oncology. 147(9). 2637–2643.
6.
Şendur, Mehmet Alı Nahıt, Burak Bi̇lgi̇n, Muhammed Bülent Akıncı, et al.. (2018). Evaluation of dynamic serum thiol/disulfide homeostasis in locally advanced and metastatic gastric cancer. SHILAP Revista de lepidopterología. 4(1). 1–4. 4 indexed citations
7.
Dede, Didem Şener, Hayriye Tatlı Doğan, Berrak Gümüşkaya, et al.. (2017). The association of programmed death-ligand 1 (PD-L1), programmed cell death (PD-1), tumor infiltrating lymphocytes(TILs) and isocitrate dehydrogenase (IDH-1) mutation in glioblastome multiforme(GBM). Annals of Oncology. 28. v110–v110. 1 indexed citations
8.
Ulaş, Arife, Kamile Sılay, Didem Şener Dede, et al.. (2015). Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey. Asian Pacific Journal of Cancer Prevention. 16(5). 1699–1705. 34 indexed citations
9.
Dede, Didem Şener, et al.. (2013). Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.. PubMed. 18(1). 57–63. 9 indexed citations
10.
Dede, Didem Şener, et al.. (2013). Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.. PubMed. 18(2). 366–71. 15 indexed citations
11.
Dızdar, Ömer, Çağatay Arslan, Tunç Eren, et al.. (2013). Breast cancer in octogenarian women: clinical characteristics and outcome.. PubMed. 18(2). 328–34. 6 indexed citations
12.
Doğan, Erkan, et al.. (2012). Pure mucinous carcinoma of the breast: a single center experience.. PubMed. 16(3). 565–7. 2 indexed citations
13.
Arslan, Çağatay, Saadettin Kılıçkap, Didem Şener Dede, et al.. (2011). 65 Yaş ve üzeri popülasyonda kanser sıklığının dağılımı: Hacettepe Üniversitesi Hastaneleri kanser kayıt sistemi sonuçları. The Turkish Journal of Geriatrics. 14(3). 187–192.
14.
Aksoy, Sercan, et al.. (2011). Sleep disturbance in patients with operable breast cancer receiving adjuvant hormone therapy.. Journal of Clinical Oncology. 29(15_suppl). e11125–e11125. 1 indexed citations
15.
Aksoy, Sercan, Didem Şener Dede, Erkan Doğan, et al.. (2010). Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.. Journal of Clinical Oncology. 28(15_suppl). e13664–e13664. 1 indexed citations
16.
Aksoy, Sercan, Hakan Harputluoğlu, Saadettin Kılıçkap, et al.. (2007). Rituximab-related viral infections in lymphoma patients. Leukemia & lymphoma. 48(7). 1307–1312. 188 indexed citations
17.
Aksoy, Sercan, Saadettin Kılıçkap, Mutlu Hayran, et al.. (2007). Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. International Journal of Laboratory Hematology. 30(3). 214–219. 47 indexed citations
18.
Dede, Didem Şener, Bünyamin Yavuz, Burcu Balam Yavuz, et al.. (2007). Assessment of Endothelial Function in Alzheimer's Disease: Is Alzheimer's Disease a Vascular Disease?. Journal of the American Geriatrics Society. 55(10). 1613–1617. 113 indexed citations
19.
Halil, Meltem, Zekeriya Ülger, Mustafa Cankurtaran, et al.. (2006). Falls and the elderly: Is there any difference in the developing world?. Archives of Gerontology and Geriatrics. 43(3). 351–359. 46 indexed citations
20.
Halil, Meltem, Mustafa Cankurtaran, Burcu Balam Yavuz, et al.. (2005). No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment. Blood Coagulation & Fibrinolysis. 16(5). 349–353. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026